Delivery Order SPE2DB22D2009-SPE2DB24FL8CP
Award Date
2/8/24
Potential Completion Date
2/9/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,863,575 units of Alfuzosin HCL ER 10 mg tablets, with a ceiling value of $16,832.49. The contract has a period of performance through September 19, 2024 and uses a Firm Fixed Price pricing structure. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Alfuzosin HCL ER 10 mg tablets. The contract is a firm fixed price, non-set-aside award with a ceiling value of $1,466.08 and a performance period ending on April 29, 2025. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price of $4,666.59 to Amerisourcebergen Drug Corp. The contract, which has no set-aside designation, is for the delivery of 4,562,266,691 tablets of Alfuzosin HCL ER 10 mg. The period of performance extends through September 22, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of 4,565,371,841 units of Alfuzosin HCL ER 10 mg tablets, a prescription medication. The order is a firm fixed-price contract with a ceiling value of $8,283.44, and the period of performance extends through August 8, 2024. AmerisourceBergen, the prime contractor, will be responsible for delivering the pharmaceutical product to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,644.03, is for the delivery of Alfuzosin HCL ER 10 mg tablets. This is a firm fixed price delivery order contract with an ultimate completion date of January 27, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,007.64, is for the delivery of Alfuzosin HCL ER 10 mg tablets. The contract is a Firm Fixed Price (FFP) contract with a completion date of July 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Alfuzosin HCL ER 10 mg tablets. The firm-fixed-price contract has a ceiling value of $1,390.10 and a performance period through August 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these prescription medications to support military treatment facilities and other federal healthcare programs. This contract award is part of a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Alfuzosin Hydrochloride Extended-Release 10 mg Tablets. The contract has a ceiling value of $1,677.32 and is a firm-fixed-price contract type. The ultimate completion date for this order is September 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,012.09 and is a Firm Fixed Price Delivery Order for the supply of Alfuzosin HCL ER 10 mg tablets. The contract has an ultimate completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,824.49 firm fixed-price contract is for the supply of Alfuzosin HCl ER 10 mg tablets. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive range of...